Gordon A. Troup is Director at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB). They have made 8 open-market trades across 2 companies since 2008, most recently 2016-04-20.
CIK 0001441122
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
8 open-market purchases totalling $155K since 2008, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NAVB | BUY | 2015-05-29 | 2015-06-01 | $1.31 | $13K | -10.6% | -5.1% | -5.1% |
| NAVB | BUY | 2013-11-08 | 2013-11-08 | $1.36 | $27K | -10.6% | -5.1% | -5.1% |
| NAVB | BUY | 2013-03-15 | 2013-03-18 | $2.70 | $19K | -10.6% | -5.1% | -5.1% |
| NAVB | BUY | 2012-08-15 | 2012-09-13 | $3.11 | $31K | -10.6% | -5.1% | -5.1% |
| NEOP | BUY | 2011-08-22 | 2011-08-23 | $2.61 | $26K | N/A | N/A | N/A |
| NEOP | BUY | 2010-11-15 | 2010-11-17 | $1.75 | $18K | N/A | N/A | N/A |
| NEOP | BUY | 2009-05-20 | 2009-11-10 | $0.70 | $10K | N/A | N/A | N/A |
| NEOP | BUY | 2008-09-12 | 2008-09-16 | $0.68 | $10K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.